MedPath

Mathematically Arterialised Testing of Hypercapnic Subjects Study

Completed
Conditions
Hypercapnic Respiratory Failure
Registration Number
NCT04072848
Lead Sponsor
Papworth Hospital NHS Foundation Trust
Brief Summary

Prospective observational cohort study of patients admitted to hospital with suspected hypercapnic respiratory failure and requiring treatment with non-invasive ventilation (NIV) as part of standard, routine management. Contemporaneous blood gas samples will be obtained via arterial, capillary, and venous methods. The venous samples will undergo mathematical arterialisation via the v-TAC system. In line with standard medical care, arterial samples will be obtained before starting NIV and at two set points afterwards (day 1 post-NIV, and pre-discharge). Pre-existing clinical thresholds will be used to assess the reliability of v-TAC against ABG, the existing gold standard and will conduct a retrospective model of decision-making once the blood sampling component of the study is concluded.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Aged 18 years or above.
  • Admitted for consideration of home Non Invasive Ventilation.
  • Due to undergo arterial blood gas sampling as part of routine clinical care
Exclusion Criteria
  • Inability to provide informed consent.
  • Clinical necessity to perform blood gas sampling prior to allowing sufficient time for informed consent.
  • Inability to obtain reliable SpO2 readings

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in blood carbon dioxide level (PaCO2)Between day 0 and day 1

Change in PaCO2 between the pre-NIV (non-invasive ventilation) and day 1 NIV samples for ABG (arterial blood gas) versus v-TAC (arterialised venous blood gas)

Secondary Outcome Measures
NameTimeMethod
Change in PaCO2 between ABG versus v-TAC versus Capillary Blood Gas (CBG) versus Venous Blood Gas (VBG)Between day 0 and through to study completion, up to 3 days

Change in PaCO2 between ABG versus v-TAC versus Capillary Blood Gas (CBG) versus Venous Blood Gas (VBG) between the pre-NIV and pre-discharge samples

Relative difficult in samplingBetween day 0 and through to study completion, up to 3 days

Frequency of sampling error rate for ABG versus CBG versus VBG versus V-TAC

Patient experienceBetween day 0 and through to study completion, up to 3 days

Using Numeric Pain Scale where 0 is no pain, 5 is moderate pain and 10 is worst pain possible

Patient preferenceBetween day 0 and through to study completion, up to 3 days

Patient preference for method of blood gas sampling will be recorded in medical records

Trial Locations

Locations (1)

Royal Papworth Hospital

🇬🇧

Cambridge, Cambridgeshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath